InsiderTrades.com logo
Missed Nvidia? Buy Elon Musk’s “Silent Partner”
From Brownstone Research   |   Ad
In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.
So please click here to see the details because a lot of people could get rich.

Stuart Grant Biography and Net Worth

Major Shareholder of Eyenovia
  • Phone
  • Email
  • Website


Stuart Grant is the Major Shareholder of Eyenovia.

What is Stuart M. Grant's net worth?

The estimated net worth of Stuart M. Grant is at least $930,977.25 as of July 2nd, 2024. Grant owns 10,914,153 shares of Eyenovia stock worth more than $930,977 as of December 21st. This net worth approximation does not reflect any other investments that Grant may own. Learn More about Stuart M. Grant's net worth.

How do I contact Stuart M. Grant?

The corporate mailing address for Grant and other Eyenovia executives is 295 MADISON AVENUE SUITE 2400, NEW YORK NY, 10017. Eyenovia can also be reached via phone at (917) 289-1117 and via email at [email protected]. Learn More on Stuart M. Grant's contact information.

Has Stuart M. Grant been buying or selling shares of Eyenovia?

Stuart M. Grant has not been actively trading shares of Eyenovia during the last ninety days. Most recently, on Tuesday, July 2nd, Stuart M. Grant bought 1,515,151 shares of Eyenovia stock. The stock was acquired at an average cost of $0.66 per share, with a total value of $999,999.66. Following the completion of the transaction, the insider now directly owns 10,914,153 shares of the company's stock, valued at $7,203,340.98. Learn More on Stuart M. Grant's trading history.

Who are Eyenovia's active insiders?

Eyenovia's insider roster includes Stuart Grant (Major Shareholder), Tsontcho Ianchulev (CEO), Kenneth Lee, Jr. (Director), Charles Mather, IV (Director), and Michael Rowe (COO). Learn More on Eyenovia's active insiders.

Are insiders buying or selling shares of Eyenovia?

In the last twelve months, Eyenovia insiders bought shares 6 times. They purchased a total of 1,752,939 shares worth more than $1,219,009.44. The most recent insider tranaction occured on August, 28th when CEO Michael M Rowe bought 27,071 shares worth more than $14,076.92. Insiders at Eyenovia own 7.1% of the company. Learn More about insider trades at Eyenovia.

Information on this page was last updated on 8/28/2024.

Stuart M. Grant Insider Trading History at Eyenovia

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/2/2024Buy1,515,151$0.66$999,999.6610,914,153View SEC Filing Icon  
3/28/2024Buy100,000$0.98$98,000.005,430,715View SEC Filing Icon  
3/19/2024Buy50,000$1.23$61,500.005,330,715View SEC Filing Icon  
3/8/2024Buy10,717$1.58$16,932.865,280,715View SEC Filing Icon  
8/16/2023Buy45,000$1.91$85,950.005,239,998View SEC Filing Icon  
5/25/2023Buy88,247$2.65$233,854.555,194,998View SEC Filing Icon  
6/21/2022Buy100,000$1.65$165,000.005,084,998View SEC Filing Icon  
5/10/2022Buy50,000$1.98$99,000.004,959,998View SEC Filing Icon  
5/4/2022Buy24,074$2.26$54,407.244,909,998View SEC Filing Icon  
4/21/2022Buy38,800$2.59$100,492.004,865,924View SEC Filing Icon  
2/22/2022Buy42,000$2.75$115,500.00View SEC Filing Icon  
2/18/2022Buy10,000$2.85$28,500.00View SEC Filing Icon  
2/7/2022Buy36,030$2.97$107,009.10View SEC Filing Icon  
12/15/2021Buy100,000$3.45$345,000.00View SEC Filing Icon  
11/15/2021Buy75,000$3.64$273,000.00View SEC Filing Icon  
10/29/2021Buy15,505$3.75$58,143.75View SEC Filing Icon  
10/25/2021Buy33,806$4.00$135,224.00View SEC Filing Icon  
8/19/2021Buy50,000$3.98$199,000.00View SEC Filing Icon  
8/17/2021Buy23,419$4.00$93,676.00View SEC Filing Icon  
4/19/2021Buy30,692$4.89$150,083.884,279,748View SEC Filing Icon  
3/5/2021Buy35,000$5.50$192,500.004,254,748View SEC Filing Icon  
10/12/2020Buy100,000$3.55$355,000.004,169,748View SEC Filing Icon  
9/24/2020Buy75,000$2.99$224,250.004,069,748View SEC Filing Icon  
8/19/2020Buy333,000$3.60$1,198,800.003,593,128View SEC Filing Icon  
3/23/2020Buy903,240$2.06$1,860,674.40View SEC Filing Icon  
11/12/2019Buy29,945$2.70$80,851.502,226,183View SEC Filing Icon  
10/30/2019Buy25,000$2.85$71,250.002,226,183View SEC Filing Icon  
10/16/2019Buy15,000$3.14$47,100.002,226,183View SEC Filing Icon  
10/14/2019Buy6,700$3.25$21,775.002,226,183View SEC Filing Icon  
10/2/2019Buy5,000$3.33$16,650.002,226,183View SEC Filing Icon  
9/30/2019Buy17,940$3.70$66,378.002,226,183View SEC Filing Icon  
9/27/2019Buy312$4.00$1,248.002,226,183View SEC Filing Icon  
See Full Table

Stuart M. Grant Buying and Selling Activity at Eyenovia

This chart shows Stuart M Grant's buying and selling at Eyenovia by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Eyenovia Company Overview

Eyenovia logo
Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.
Read More

Today's Range

Now: $0.09
Low: $0.08
High: $0.09

50 Day Range

MA: $0.29
Low: $0.08
High: $0.57

2 Week Range

Now: $0.09
Low: $0.08
High: $2.57

Volume

14,142,422 shs

Average Volume

3,200,527 shs

Market Capitalization

$7.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.43
Missed Nvidia? Buy Elon Musk’s “Silent Partner”
From Brownstone Research   |   Ad
In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.
So please click here to see the details because a lot of people could get rich.